News

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs’ Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed and cost advantages working with their company TetraQ toxicology for pre-clinical research in Australia.

TetraQ is a NATA-accredited, GLP-recognised rodent toxicology facility.

COVID-19 Vaccine Moves Forward

COVID-19 Vaccine Moves Forward

Researchers at The University of Queensland, with support from the Coalition for Epidemic Preparedness Innovations (CEPI), are moving forward rapidly on development of a potential vaccine against COVID-19. TetraQ's in-life facility at St Lucia is undertaking...

read more
TetraQ Welcomes Leonora Pearson

TetraQ Welcomes Leonora Pearson

Leonora Pearson has joined TetraQ as our new Quality Assurance Manager, replacing long-term QA head Simon Lake.  Leonora comes to us from Invetus in Armidale, where she was responsible for the management and maintenance of their quality systems to ensure the continued...

read more